Scientists question safety and benefits of three-parent IVF as new UK data raise concerns

The mitochondrial replacement technique, often called three‑parent IVF, was hailed after the United Kingdom reported the birth of eight healthy children whose mothers carried disease‑causing mitochondrial mutations. The procedure combines nuclear DNA from the parents with mitochondria from a donor egg, aiming to prevent the transmission of rare, sometimes fatal, mitochondrial diseases.

New analyses of the UK outcomes are prompting scientists and ethicists to reassess the technology’s risk‑benefit profile. Emerging data suggest potential unforeseen complications, and the debate now focuses on whether the long‑term health impacts for the children have been fully understood.

While the United Kingdom and Australia move forward with regulated use of the technique, the United States continues to ban it. The latest concerns are fueling discussions among regulators and the research community about how, or if, the procedure should be expanded globally.